cefixime has been researched along with Infections, Klebsiella in 4 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a prospective, open clinical study, 50 urological patients with acute pyelonephritis were treated with the oral cephalosporin cefixime." | 9.06 | [Effectiveness and tolerance of cefixime in the treatment of acute pyelonephritis]. ( Segal, A; Tröster, K; Weissbach, L, 1990) |
| "One hundred six patients with acute, uncomplicated lower urinary tract infections participated in a randomized study that compared cefixime (one 400-mg tablet once daily) with trimethoprim (160 mg)/sulfamethoxazole (800 mg) (one tablet every 12 hours)." | 9.06 | Cefixime versus trimethoprim/sulfamethoxazole in treatment of patients with acute, uncomplicated lower urinary tract infections. ( Cox, CE, 1989) |
| "In a prospective, open clinical study, 50 urological patients with acute pyelonephritis were treated with the oral cephalosporin cefixime." | 5.06 | [Effectiveness and tolerance of cefixime in the treatment of acute pyelonephritis]. ( Segal, A; Tröster, K; Weissbach, L, 1990) |
| "One hundred six patients with acute, uncomplicated lower urinary tract infections participated in a randomized study that compared cefixime (one 400-mg tablet once daily) with trimethoprim (160 mg)/sulfamethoxazole (800 mg) (one tablet every 12 hours)." | 5.06 | Cefixime versus trimethoprim/sulfamethoxazole in treatment of patients with acute, uncomplicated lower urinary tract infections. ( Cox, CE, 1989) |
| "Cefixime was the commonly prescribed antimicrobial (p = 0." | 1.48 | Antimicrobial misuse in pediatric urinary tract infections: recurrences and renal scarring. ( Jayaweera, JAAS; Reyes, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jayaweera, JAAS | 1 |
| Reyes, M | 1 |
| Alsuwaidi, AR | 1 |
| Albawardi, A | 1 |
| Khan, NH | 1 |
| Souid, AK | 1 |
| Weissbach, L | 1 |
| Segal, A | 1 |
| Tröster, K | 1 |
| Cox, CE | 1 |
2 trials available for cefixime and Infections, Klebsiella
| Article | Year |
|---|---|
[Effectiveness and tolerance of cefixime in the treatment of acute pyelonephritis].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Body Temperature; Cef | 1990 |
Cefixime versus trimethoprim/sulfamethoxazole in treatment of patients with acute, uncomplicated lower urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Drug Administration Schedule; Escherichia coli | 1989 |
2 other studies available for cefixime and Infections, Klebsiella
| Article | Year |
|---|---|
Antimicrobial misuse in pediatric urinary tract infections: recurrences and renal scarring.
Topics: Anti-Bacterial Agents; Biofilms; Cefixime; Child; Child, Preschool; Cicatrix; Escherichia coli; Esch | 2018 |
A 4-month-old baby presenting with dermal necrotizing granulomatous giant cell reaction at the injection site of 13-valent pneumococcal conjugate vaccine: a case report.
Topics: Anti-Bacterial Agents; Biopsy; Cefixime; Diagnosis, Differential; Erythema Induratum; Giant Cells; G | 2014 |